This portal should only be accessed by patients who have been prescribed this medicine by their Healthcare Professional.
These resources are only to be provided to patients who have already been prescribed Hemlibra® (emicizumab) by their physician.
They need to be used along with the Patient Information Leaflets and additional Risk Minimisation Materials provided to you by your healthcare provider, namely ‘Hemlibra® (emicizumab): Patient/Carer Guide‘ and ‘Hemlibra® (emicizumab): Patient Alert Card’.
ROCHE PRODUCTS (IRELAND) LIMITED COOKIE NOTICE
About
We are Roche Products (Ireland) Limited of 3004, Lake Drive, City West, Naas Road, Dublin 24 (“Roche”, “us”, “we”, or “our”), the owner and operator of https://www.rocheresource.ie/ (the “Site”).
Information about our use of cookies
The Site uses cookies to distinguish you from other users of the Site. This helps us to provide you with a more personalised experience when you browse the Site and also allows us to improve the Site. Some of the cookies we are using require processing of your IP address for the cookies to work and the Site to operate properly. We don’t identify your IP address as we have no purpose in doing so.
What is a cookie?
A cookie is a small data file that we place and store on your device. The cookies that we use make the Site work properly and optimise its security. Further details are included below.
What cookies do we use?
At the moment, we use only what are referred to as Essential Cookies. These are cookies that are required for the operation of the Site. They include, for example, cookies that enable you to log into secure areas of the Site and to move around the Site. These cookies do not gather any information about you that could be used for marketing or advertising and they do not collect information about other browsing that you do on the internet. These Essential Cookies cannot be disabled. More details about them are set out in the table below.
We don’t use any non-essential cookies at present, including any analytical/performance cookies (which would allow us to recognise and count the number of visitors to the Site and/or to see how visitors move around the Site and what pages are most popular), functionality cookies (which enables us to recognise return visitors and personalise content for them) or targeting cookies (which enable us to recognise return visitors and direct more targeted content to them). However, we may use such cookies in future. If we do so, we will update this Cookie Notice and, before we deploy such cookies on users’ devices, we will obtain their consent via a cookie consent tool.
More information about the Essential Cookies that we use is set out in the table below.
Cookie Name |
Purpose |
__cfduid |
CloudFlare cookie, used to speed up page load times. This cookie is essential for this site to ensure that all elements such as a code, images etc., are loaded efficiently in a user’s browser. |
otSession ID |
This cookie is technology related and is necessary for the purpose of local industry governance and compliance reasons. It is used to ensure that the access code entered by a user corresponds with the correct access code hidden in our database and thus enables the user to gain access to a secure area. |
renderid |
When a user starts a session it needs to be linked to a specific published version of the web page they are viewing to prevent session data loss. This cookie is used to determine which published version is serving content for a specific user's session. |
geolp |
This is a functional cookie to convert a user’s IP address into a geographic location record. It is technology related and is essential. |
Managing cookies
Essential cookies cannot be disabled.
You can block cookies by activating the setting on your browser that allows you to refuse the setting of all or some cookies. You can access the “Help” function in your browser to find out more. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or parts of the Site. Below are links to information for standard browsers about how to block cookies (including third party cookies described below).
Chrome : https://support.google.com/accounts/answer/61416?co=GENIE.Platform%3DDesktop&hl=en
Internet Explorer: https://support.microsoft.com/en-ie/help/17442/windows-internet-explorer-delete-manage-cookie
Firefox : https://support.mozilla.org/en-US/kb/block-websites-storing-cookies-site-data-firefox
Safari : https://support.apple.com/en-ie/guide/safari/sfri11471/mac
Safari Mobile Browser : https://support.apple.com/en-ie/HT201265
Opera : https://blogs.opera.com/news/2015/08/how-to-manage-cookies-in-opera/
Third Party Cookies
Third party cookies are cookies deployed on your device by someone other than us for purposes such as collecting information on user behaviour, demographics, or for personalising marketing or advertising messages to you based on your browsing on the internet.
We do not permit third party cookies on the Site.
More information
For more information, please contact our Data Protection Co-Ordinator by email at pat.lennon@roche.com.
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. Patients and Healthcare professionals are asked to report any suspected adverse reactions.
Please report any suspected adverse events (side effects) to:
The Drug Surveillance Centre
Pharmacovigilance department
Roche Products (Ireland) Limited
3004 Lake Drive, Citywest,
Naas Road, Dublin 24
Telephone: (01) 4690700
Email: ireland.drug_surveillance_centre@roche.com
Webform: https://medinfo.roche.com/ie/en.html
Alternatively, any suspected adverse reactions (side effects) can be reported to:
HPRA Pharmacovigilance
Website: www.hpra.ie